FDA "Drug Watch" Listing Removal Criteria Need Greater Clarity - PhRMA

FDA's criteria for removing a product from the proposed "Drug Watch" website are subjective and will make it difficult, if not impossible, for a drug to be taken off the list, the Pharmaceutical Research & Manufacturers of America said